Nexsen Limited

A$0.17As of Sun 8 Nov 2026, 12:00 UTC
ASX:NXNHealthcare
Country Australia
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (236.38%)
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM (25.00%)
Mkt cap A$33.03M
ROIC (580.48%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.192
16.39%
232.80%
Buy 12|12|4|4|1
2Q26
3Q26
4Q26
1Q27
Earnings per share$
—
—
—
—
(1.92%)
12.75%
9.51%
25.15%
Revenue$M
2.205
2.282
2.291
2.321
10.41%
11.52%
12.50%
8.68%
Peers (US$22.69M)
Cap (US$)
PE
21.26M
—
Capital
TTM
5Y
10Y
Leveragex
0.260
(0.063)
(0.053)
EBIT/Intx
2.088
0.966
0.871
Own earn%
(30.80)
23.75
27.23
Sh yield%
36.89
25.57
25.74
Owners
Insiders/Inst%
8.25
28.73
Short interest%
4.44
SBC / revenue%
2.76
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
3–7
$1 testx
0.0
Incr. ROIC%
6